Cancer Epidemiology Biomarkers & Prevention, Vol 6, Issue 10 791-797, Copyright © 1997 by American Association for Cancer Research

ARTICLES

CYP1A1 and GSTM1 polymorphisms and oral cancer risk [published erratum appears in Cancer Epidemiol Biomarkers Prev 1997 Dec;6(12):1108]

JY Park, JE Muscat, Q Ren, SP Schantz, RD Harwick, JC Stern, V Pike, JP Richie Jr and P Lazarus
Department of Pathology, School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, USA.

The importance of both the CYP1A1 exon 7 (ile:val) and GSTM1 (0/0) polymorphisms in oral cancer susceptibility was assessed by examining polymorphic prevalences in 135 patients with oral cancer and 135 noncancer controls frequency-matched by age at diagnosis (+/- 5 years), race, sex, and institute of patient recruitment. The prevalence of the GSTM1 (0/0) genotype was approximately 51% in both cases and controls. The prevalence of the CYP1A1 (ile:val) polymorphism [including both the (ile/val) and (val/val) genotypes] was significantly higher in cases as compared to controls (17.6% versus 7.6%, respectively; crude odds ratio, 2.6; confidence interval, 1.2-5.7). No association was observed between polymorphic prevalence and levels of smoking or alcohol consumption in cases. These results suggest that the GSTM1 null genotype is not associated with oral cancer risk. These results also suggest that individuals with the CYP1A1 exon 7 ile:val polymorphism are at increased risk for oral cancer, and that this risk may not be influenced by differences in exposure to tobacco smoke.

This article has been cited by other articles:

				C. J. Gallagher, J. E. Muscat, A. N. Hicks, Y. Zheng, A.-M. Dyer, G. A. Chase, J. Richie, and P. Lazarus The UDP-Glucuronosyltransferase 2B17 Gene Deletion Polymorphism: Sex-Specific Association with Urinary 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol Glucuronidation Phenotype and Risk for Lung Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 823 - 828. [Abstract] [Full Text] [PDF]

				J. Park, L. Chen, L. Ratnashinge, T. A. Sellers, J.-P. Tanner, J.-H. Lee, N. Dossett, N. Lang, F. F. Kadlubar, C. B. Ambrosone, et al. Deletion Polymorphism of UDP-Glucuronosyltransferase 2B17 and Risk of Prostate Cancer in African American and Caucasian Men. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1473 - 1478. [Abstract] [Full Text] [PDF]

				L. F. Masson, L. Sharp, S. C. Cotton, and J. Little Cytochrome P-450 1A1 Gene Polymorphisms and Risk of Breast Cancer: A HuGE Review Am. J. Epidemiol., May 15, 2005; 161(10): 901 - 915. [Abstract] [Full Text] [PDF]

				Z Ye, H Song, and Y Guo Glutathione S-transferase M1, T1 status and the risk of head and neck cancer: a meta-analysis J. Med. Genet., May 1, 2004; 41(5): 360 - 365. [Full Text] [PDF]

				Y. Zhu, M. R. Spitz, C. I. Amos, J. Lin, M. B. Schabath, and X. Wu An Evolutionary Perspective on Single-Nucleotide Polymorphism Screening in Molecular Cancer Epidemiology Cancer Res., March 15, 2004; 64(6): 2251 - 2257. [Abstract] [Full Text] [PDF]

				M. Hashibe, P. Brennan, R. C. Strange, R. Bhisey, I. Cascorbi, P. Lazarus, M. B. O. Ophuis, S. Benhamou, W. D. Foulkes, T. Katoh, et al. Meta- and Pooled Analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 Genotypes and Risk of Head and Neck Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1509 - 1517. [Abstract] [Full Text] [PDF]

				A. Elahi, Z. Zheng, J. Park, K. Eyring, T. McCaffrey, and P. Lazarus The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk Carcinogenesis, July 1, 2002; 23(7): 1229 - 1234. [Abstract] [Full Text] [PDF]

				Z. Zheng, J. Y. Park, C. Guillemette, S. P. Schantz, and P. Lazarus Tobacco Carcinogen-Detoxifying Enzyme UGT1A7 and Its Association With Orolaryngeal Cancer Risk J Natl Cancer Inst, September 19, 2001; 93(18): 1411 - 1418. [Abstract] [Full Text] [PDF]

				Y. Zheng, H. Shen, E. M. Sturgis, L.-E Wang, S. A. Eicher, S. S. Strom, M. L. Frazier, M. R. Spitz, and Q. Wei Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study Carcinogenesis, August 1, 2001; 22(8): 1195 - 1199. [Abstract] [Full Text] [PDF]

				S. A. Geisler and A. F. Olshan GSTM1, GSTT1, and the Risk of Squamous Cell Carcinoma of the Head and Neck: A Mini-HuGE Review Am. J. Epidemiol., July 15, 2001; 154(2): 95 - 105. [Abstract] [Full Text] [PDF]

				Y. Ko, J. Abel, V. Harth, P. Brode, C. Antony, S. Donat, H.-P. Fischer, M. E. Ortiz-Pallardo, R. Thier, A. Sachinidis, et al. Association of CYP1B1 Codon 432 Mutant Allele in Head and Neck Squamous Cell Cancer Is Reflected by Somatic Mutations of p53 in Tumor Tissue Cancer Res., June 1, 2001; 61(11): 4398 - 4404. [Abstract] [Full Text] [PDF]

				T. B. Kaur, J. M. Travaline, J. P. Gaughan, J. P. Richie Jr., S. D. Stellman, and P. Lazarus Role of Polymorphisms in Codons 143 and 160 of the O6-Alkylguanine DNA Alkyltransferase Gene in Lung Cancer Risk Cancer Epidemiol. Biomarkers Prev., March 1, 2000; 9(3): 339 - 342. [Abstract] [Full Text]

				A. F. Olshan, M. C. Weissler, M. A. Watson, and D. A. Bell GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 Polymorphisms, Tobacco Use, and the Risk of Head and Neck Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2000; 9(2): 185 - 191. [Abstract] [Full Text]

				H. Bartsch, U. Nair, A. Risch, M. Rojas, H. Wikman, and K. Alexandrov Genetic Polymorphism of CYP Genes, Alone or in Combination, as a Risk Modifier of Tobacco-related Cancers Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 3 - 28. [Abstract] [Full Text]

				W. P. Bennett, M. C. R. Alavanja, B. Blomeke, K. H. Vahakangas, K. Castren, J. A. Welsh, E. D. Bowman, M. A. Khan, D. B. Flieder, and C. C. Harris Environmental Tobacco Smoke, Genetic Susceptibility, and Risk of Lung Cancer in Never-Smoking Women J Natl Cancer Inst, December 1, 1999; 91(23): 2009 - 2014. [Abstract] [Full Text] [PDF]

				M. Sato, T. Sato, T. Izumo, and T. Amagasa Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer Carcinogenesis, October 1, 1999; 20(10): 1927 - 1931. [Abstract] [Full Text] [PDF]

				C. Matthias, V. Jahnke, P. W. Jones, P. R. Hoban, J. E. Alldersea, S. F. Worrall, A. A. Fryer, and R. C. Strange Cyclin D1, Glutathione S-Transferase, and Cytochrome P450 Genotypes and Outcome in Patients with Upper Aerodigestive Tract Cancers: Assessment of the Importance of Individual Genes Using Multivariate Analysis Cancer Epidemiol. Biomarkers Prev., September 1, 1999; 8(9): 815 - 823. [Abstract] [Full Text]

				U. J. Nair, J. Nair, B. Mathew, and H. Bartsch Glutathione S-transferase M1 and T1 null genotypes as risk factors for oral leukoplakia in ethnic Indian betel quid/tobacco chewers Carcinogenesis, May 1, 1999; 20(5): 743 - 748. [Abstract] [Full Text] [PDF]